Related Experiment Video
Updated: Jul 5, 2025

08:51
Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla
Published on: February 19, 2021
9.0K
A Radiomic "Warning Sign" of Progression on Brain MRI in Individuals with MS
Brendan S Kelly1,2,3,4, Prateek Mathur2, Gerard McGuinness5
1From the Department of Radiology (B.S.K., G.M., H.D., R.P.K.), St. Vincent's University Hospital, Dublin, Ireland brendanskelly@me.com.
AJNR. American Journal of Neuroradiology
|January 12, 2024
Summary
Machine learning models using radiomics features can predict multiple sclerosis (MS) progression by analyzing brain MR imaging. This approach identifies early biomarkers in normal-appearing white matter, aiding in disease management.
Area of Science:
- Neurology
- Medical Imaging
- Machine Learning
Background:
- Multiple Sclerosis (MS) is a chronic, progressive demyelinating disorder.
- Diagnosis and monitoring of MS heavily rely on Magnetic Resonance (MR) imaging.
- New MR imaging lesions are critical early indicators of disease progression.
Purpose of the Study:
- To assess a machine learning model utilizing radiomics features for predicting MS progression on brain MR imaging.
- To identify potential imaging biomarkers for early detection of MS progression.
Main Methods:
- A retrospective cohort study with external validation was conducted.
- Longitudinal MR imaging data from MS patients were processed for machine learning.
- Radiomics features were extracted from prelesion areas and normal-appearing white matter.
Main Results:
- The best-performing model (XGBoost) achieved high accuracy (0.91) on the test set and good performance (0.74) on external validation.
- Key radiomics features were related to heterogeneity and gray-level emphasis in segmented regions.
- Probability maps were generated for potential clinical applications.
Conclusions:
- Machine learning models based on radiomics features can effectively distinguish prelesions from normal-appearing white matter.
- Radiomics features from normal-appearing white matter show promise as imaging biomarkers for MS progression.

